Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.67 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.62 |
| ▸ | NT5E | P21589 | 1/20 | 0.62 |
| ▸ | KRAS | P01116 | 5/20 | 0.62 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.58 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.58 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.58 |
| ▸ | IMPDH2 | P12268 | 4/20 | 0.58 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.57 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.57 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.57 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.57 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.56 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.56 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.56 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.56 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.56 |
| ▸ | HINT1 | P49773 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Fucose SCHEMBL18992533 | 1.00 | TGM2 (0.67) | TGM2FUT5NT5EKRASP2RY6 | |
| L-Fucose SCHEMBL29216038 | 0.97 | TGM2 (0.63) | TGM2FUT5NT5EKRASP2RY6 | |
| Demannose SCHEMBL2182862 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 | |
| Glucuronic Acid SCHEMBL27957333 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 | |
| Demannose SCHEMBL5163477 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 | |
| Demannose SCHEMBL4290630 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 | |
| Galactose SCHEMBL6046113 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 | |
| Demannose SCHEMBL20746287 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 | |
| Glucuronic Acid SCHEMBL6046180 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 | |
| Glucuronic Acid SCHEMBL5941537 | 0.92 | TGM2 (0.66) | TGM2FUT5NT5EKRASP2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118165926-A | Preparation method and application of targeted stem cells | 天津大学 | 2024-06-11 | — | — | CN | claimed |
| CN-114574506-A | Protein O-fucosyltransferase OsPOFUT1 encoding gene and enzyme, preparation and application thereof | 中国科学院大连化学物理研究所 | 2022-06-03 | — | — | CN | claimed |
| CN-114207108-A | Genetically modified host cells producing glycosylated cannabinoids | 奥克塔林生物制剂公司 | 2022-03-18 | — | — | CN | claimed |
| EP-4422642-B1 | RUTINOSYL-4-METHYLUMBELLIFERONE FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA | CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN CONICET (AR) | 2026-02-04 | — | — | EP | disclosed |
| US-20250222114-A1 | GLYCOCONJUGATED DRUG FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA | ASOCIACIÓN CIVIL DE ESTUDIOS SUPERIORES - UNIVERSIDAD AUSTRAL (AR) | 2025-07-10 | — | — | US | disclosed |
| EP-4422642-A1 | GLYCOCONJUGATED DRUG FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA | Consejo Nacional de Investigaciones Científicas Y Técnicas (CONICET) (AR) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024123084-A1 | METHOD FOR PRODUCING FUCOSYLLACTOSE BY USING RECOMBINANT CORYNEBACTERIUM GLUTAMICUM TRANSFORMED TO EXPRESS BETA-GALACTOSIDASE | (주)에이피테크놀로지 | 2024-06-13 | — | — | WO | disclosed |
| CN-118165926-A | Preparation method and application of targeted stem cells | 天津大学 | 2024-06-11 | — | — | CN | disclosed |
| CN-118028206-A | Engineering bacterium for preparing L-fucose and application thereof | 华熙生物科技股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-20240093254-A1 | METHOD FOR INCREASING PRODUCTIVITY OF 2'-FUCOSYLLACTOSE THROUGH CHANGES IN CULTURE MEDIUM COMPOSITION AND CULTURING | ADVANCED PROTEIN TECHNOLOGIES CORP. (KR) | 2024-03-21 | — | — | US | disclosed |
| CN-117721089-A | Enzyme composition and application thereof | 珠海瑞德林生物有限公司 | 2024-03-19 | — | — | CN | disclosed |
| US-20200181665-A1 | FUCOSYLTRANSFERASES AND THEIR USE IN PRODUCING FUCOSYLATED OLIGOSACCHARIDES | CHR. HANSEN A/S (DK) | 2020-06-11 | — | — | US | disclosed |
| EP-3649248-A1 | FUCOSYLTRANSFERASES AND THEIR USE IN PRODUCING FUCOSYLATED OLIGOSACCHARIDES | Jennewein Biotechnologie GmbH (DE) | 2020-05-13 | — | — | EP | disclosed |
| US-20200140895-A1 | Recombinant bacillus subtilis for synthesizing GDP-L-fucose and application thereof | JIANGNAN UNIVERSITY (CN) | 2020-05-07 | — | — | US | disclosed |
| CN-110869508-A | Fucosyltransferases and their use in the production of fucosylated oligosaccharides | 詹尼温生物技术有限责任公司 | 2020-03-06 | — | — | CN | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| CN-109749976-A | A kind of recombined bacillus subtilis efficiently synthesizing guanosine diphosphate fucose and its construction method and application | 光明乳业股份有限公司 | 2019-05-14 | — | — | CN | disclosed |
| WO-2019008133-A1 | FUCOSYLTRANSFERASES AND THEIR USE IN PRODUCING FUCOSYLATED OLIGOSACCHARIDES | JENNEWEIN BIOTECHNOLOGIE GMBH (DE) | 2019-01-10 | — | — | WO | disclosed |
| EP-3425052-A1 | FUCOSYLTRANSFERASES AND THEIR USE IN PRODUCING FUCOSYLATED OLIGOSACCHARIDES | Jennewein Biotechnologie GmbH (DE) | 2019-01-09 | — | — | EP | disclosed |
| CN-106795484-A | For α (1,2) the fucosyltransferase mutation used when fucosylation oligosaccharide is produced | 格里康辛有限责任公司 | 2017-05-31 | — | — | CN | disclosed |